Oncotarget

Research Papers:

This article has been retracted. Retraction in: Oncotarget. 2019; 10:5588-5588.

DNA-PKCS binding to p53 on the p21WAF1/CIP1 promoter blocks transcription resulting in cell death

Richard Hill, Patricia A. Madureira, David M Waisman and Patrick W.K. Lee _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2011; 2:1094-1108. https://doi.org/10.18632/oncotarget.378

Metrics: PDF 1643 views  |   HTML 2314 views  |   ?  


Abstract

Richard Hill1, Patricia A. Madureira2, David. M. Waisman2 and Patrick W.K. Lee1,3

1 Department of Microbiology & Immunology, Dalhousie University, Halifax, Nova Scotia, Canada

2 Department of Biochemistry and Molecular Biology, Dalhousie University, Halifax, Nova Scotia, Canada

3 Department of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada

Received: December 8, 2011; Accepted: December 9, 2011; Published: December 20, 2011;

Keywords: DNA-PKCs, p53, p21 transcription suppression

Correspondence:

Patrick W.K. Lee, email:

Abstract

A key determinant of p53-mediated cell fate following various DNA damage modalities is p21WAF1/CIP1 expression, with elevated p21 expression triggering cell cycle arrest and repressed p21 expression promoting apoptosis. We show that under pro-death DNA damage conditions, the DNA-dependent protein kinase (DNA-PKCS) is recruited to the p21 promoter where it forms a protein complex with p53. The DNA-PKCS-associated p53 displays post-translational modifications that are distinct from those under pro-arrest conditions, ablating p21 transcription and inducing cell death. Inhibition of DNA-PK activity prevents DNA-PKCS binding to p53 on the p21 promoter, restores p21 transcription and significantly reduces cell death. These data demonstrate that DNA-PKCS negatively regulates p21 expression by directly interacting with the p21 transcription machinery via p53, driving the cell towards apoptosis.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 378